Rituximab in Recurrent IgA Nephropathy
NCT02571842
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Recurrent IgA Nephropathy
Interventions
DRUG:
Intravenous Rituximab
DRUG:
ACEI/ARB and corticosteroids
Sponsor
Chulalongkorn University